N Stahnke

875 total citations
52 papers, 622 citations indexed

About

N Stahnke is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, N Stahnke has authored 52 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Pediatrics, Perinatology and Child Health and 11 papers in Molecular Biology. Recurrent topics in N Stahnke's work include Growth Hormone and Insulin-like Growth Factors (23 papers), Pituitary Gland Disorders and Treatments (10 papers) and Sexual Differentiation and Disorders (9 papers). N Stahnke is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (23 papers), Pituitary Gland Disorders and Treatments (10 papers) and Sexual Differentiation and Disorders (9 papers). N Stahnke collaborates with scholars based in Germany, United States and Latvia. N Stahnke's co-authors include R. P. Willig, H.‐C. Steinhausen, I Lagenstein, Hans Zeisel, G. Grübel, Markus Bettendorf, Otto Mehls, E Keller, Hal Landy and Michael B. Ranke and has published in prestigious journals such as Human Reproduction, Archives of Disease in Childhood and Clinical Endocrinology.

In The Last Decade

N Stahnke

48 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Stahnke Germany 13 323 242 238 127 63 52 622
Ronald W. Gotlin United States 10 278 0.9× 334 1.4× 339 1.4× 78 0.6× 60 1.0× 18 674
A Johanson United States 11 542 1.7× 201 0.8× 145 0.6× 122 1.0× 90 1.4× 16 690
C. P. Schwarze Germany 15 325 1.0× 234 1.0× 249 1.0× 173 1.4× 89 1.4× 26 671
RG Rosenfeld United States 17 598 1.9× 324 1.3× 212 0.9× 104 0.8× 57 0.9× 30 746
Juliane Léger France 15 564 1.7× 320 1.3× 357 1.5× 315 2.5× 108 1.7× 26 1.1k
J. A. Batch Australia 10 163 0.5× 183 0.8× 194 0.8× 51 0.4× 60 1.0× 16 448
Jiřina Zapletalová Czechia 14 237 0.7× 171 0.7× 225 0.9× 83 0.7× 52 0.8× 39 553
Nuvarte Setian Brazil 15 283 0.9× 248 1.0× 360 1.5× 121 1.0× 109 1.7× 63 731
Elena P. Shavrikova Germany 10 549 1.7× 234 1.0× 295 1.2× 203 1.6× 42 0.7× 14 732
Val Abbassi United States 12 269 0.8× 113 0.5× 155 0.7× 147 1.2× 93 1.5× 24 643

Countries citing papers authored by N Stahnke

Since Specialization
Citations

This map shows the geographic impact of N Stahnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Stahnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Stahnke more than expected).

Fields of papers citing papers by N Stahnke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Stahnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Stahnke. The network helps show where N Stahnke may publish in the future.

Co-authorship network of co-authors of N Stahnke

This figure shows the co-authorship network connecting the top 25 collaborators of N Stahnke. A scholar is included among the top collaborators of N Stahnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Stahnke. N Stahnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dörr, Helmuth G., Markus Bettendorf, Berthold P. Hauffa, et al.. (2011). Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children. Clinical Endocrinology. 75(5). 656–660. 11 indexed citations
2.
Mehls, Otto, Anders Lindberg, Markus Bettendorf, et al.. (2009). Is the Response to Growth Hormone in Short Children Born Small for Gestational Age Dependent on Genetic or Maternal Factors?. Hormone Research in Paediatrics. 72(2). 106–113. 5 indexed citations
3.
Bettendorf, Markus, H. G. Doerr, Berthold P. Hauffa, et al.. (2006). Prevalence of Autoantibodies Associated with Thyroid and Celiac Disease in Ullrich-Turner Syndrome in Relation to Adult Height After Growth Hormone Treatment. Journal of Pediatric Endocrinology and Metabolism. 19(2). 149–154. 24 indexed citations
4.
Doerr, H. G., Markus Bettendorf, Berthold P. Hauffa, et al.. (2005). Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Human Reproduction. 20(5). 1418–1421. 37 indexed citations
5.
Stahnke, N. (2004). Ullrich-Turner-Syndrom und Noonan-Syndrom. Monatsschrift Kinderheilkunde. 152(5). 517–527. 4 indexed citations
6.
Ranke, MB, Anders Lindberg, H. G. Dörr, et al.. (2002). Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. European Journal of Endocrinology. 147(5). 625–633. 63 indexed citations
7.
8.
Flitsch, Jörg, et al.. (2000). Transsphenoidal Surgery for Pituitary Gigantism and Galactorrhea in a 3.5 Year Old Child. Pituitary. 2(4). 261–267. 7 indexed citations
9.
Stahnke, N. (1992). Leukemia in Growth-Hormone Treated Patients: An Update, 1992. Hormone Research. 38(1). 56–62. 49 indexed citations
10.
Stahnke, N, et al.. (1992). Recombinant Human Growth Hormone and Oxandrolone in Treatment of Short Stature in Girls with Turner Syndrome. Hormone Research. 37(2). 37–46. 11 indexed citations
11.
Frasier, S. Douglas, N Stahnke, E Cacciari, et al.. (1992). Growth Response to Recombinant Human Growth Hormone of Mammalian Cell Origin in Prepubertal Growth Hormone-Deficient Children during the First Two Years of Treatment. Hormone Research. 37(2). 28–36. 7 indexed citations
12.
Stahnke, N, et al.. (1990). Replacement Therapy in Hypothalamus-Pituitary Insufficiency: Management in the Adolescent. Hormone Research. 33(4). 38–44. 7 indexed citations
13.
Sinnecker, Gernot H.G., R. P. Willig, N Stahnke, & W. Braendle. (1989). Precocious pseudopuberty associated with multiple ovarian follicular cysts and low plasma oestradiol concentrations. European Journal of Pediatrics. 148(7). 600–602. 6 indexed citations
14.
Stahnke, N & Hans Zeisel. (1989). Growth hormone therapy and leukaemia. European Journal of Pediatrics. 148(7). 591–596. 38 indexed citations
15.
Stahnke, N, Elena Stenzel, & H. H. Hellwege. (1986). Thyroid function in prematures with respiratory distress syndrome (RDS). European Journal of Endocrinology. 113(4_Suppl). S354–S360. 4 indexed citations
16.
Stahnke, N, et al.. (1985). 101 OXANDROLONE INCREASED FINAL HEIGHT IN TURNER'S SYNDROME (TS). Pediatric Research. 19(6). 620–620. 7 indexed citations
17.
Stahnke, N, G. Grübel, I Lagenstein, & R. P. Willig. (1984). Long-term follow-up of children with craniopharyngioma. European Journal of Pediatrics. 142(3). 179–185. 73 indexed citations
18.
Stahnke, N, et al.. (1981). Effect of chronic renal failure on insulin, GH, thyroid hormone, gluco- and mineralocorticoid, ACTH and gonadotropin levels. Pediatric Research. 15(12). 1551–1551. 2 indexed citations
19.
Christiansen, Danny, et al.. (1980). [Conditions and results of estrogen therapy of extremely tall young girls].. PubMed. 128(12). 787–8. 4 indexed citations
20.
Steinhausen, H.‐C. & N Stahnke. (1976). Psychoendocrinological studies in dwarfed children and adolescents.. Archives of Disease in Childhood. 51(10). 778–783. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald W. Gotlin Breakdown of academic impact, for papers by A Johanson Breakdown of academic impact, for papers by C. P. Schwarze Breakdown of academic impact, for papers by RG Rosenfeld Breakdown of academic impact, for papers by Juliane Léger Breakdown of academic impact, for papers by J. A. Batch Breakdown of academic impact, for papers by Jiřina Zapletalová Breakdown of academic impact, for papers by Nuvarte Setian Breakdown of academic impact, for papers by Elena P. Shavrikova Breakdown of academic impact, for papers by Val Abbassi
Rankless by CCL
2026